# Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer

> **NCT06164691** · NA · TERMINATED · sponsor: **Matthew Neal MD** · enrollment: 2 (actual)

## Conditions studied

- Pancreatic Neoplasms
- Rectal Neoplasms

## Interventions

- **DEVICE:** Blue light
- **DEVICE:** Amber light
- **OTHER:** Ambient White Light

## Key facts

- **NCT ID:** NCT06164691
- **Lead sponsor:** Matthew Neal MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-14
- **Primary completion:** 2023-04-29
- **Final completion:** 2023-04-29
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** PI terminated study due to lack of enrollment.
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164691, "Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06164691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*